Hospira has a total of 1056 patents globally, out of which 474 have been granted. Of these 1056 patents, more than 23% patents are active. United States of America is where Hospira has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Hospira.
Hospira was founded in the year 2004. The Company manufactures and sells generic pharmaceutical products.
Do read about some of the most popular patents of Hospira which have been covered by us in this article and also you can find Hospira patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hospira patent portfolio.
How many patents does the founder of Hospira have?
The founder Martin Mugume Namani has 0 patent.
How many patents does Hospira have?
Hospira has a total of 1056 patents globally. These patents belong to 250 unique patent families. Out of 1056 patents, 247 patents are active.
How Many Patents did Hospira File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Hospira Applications Filed | Hospira Patents Granted |
| 2023 | 1 | 2 |
| 2022 | – | 3 |
| 2021 | 3 | 7 |
| 2020 | 12 | 13 |
| 2019 | 19 | 26 |
| 2018 | 15 | 43 |
| 2017 | 10 | 38 |
| 2016 | 9 | 26 |
| 2015 | 34 | 24 |
| 2014 | 31 | 32 |
| 2013 | 66 | 23 |
| 2012 | 144 | 20 |
Which Hospira Drug Patents are Expiring in the Next 10 Years?
The patent no. US9320712B2 which is expiring in Jan, 2032, describing the disclosure involves pharmaceutical compositions containing dexmedetomidine or its salt formulated as a liquid for injecting into a patient. The composition is pre-mixed and stored in a sealed container. These compositions are useful in tasks like perioperative care or sedation of patients.
Given below is the list of few drugs patented by Hospira accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Precedex | US9320712B2 | Dexmedetomidine premix formulation | Jan, 2032 |
| Daptomycin | US9655946B2 | Daptomycin formulations and uses… | Sep, 2033 |
| Dyloject | US8946292B2 | Formulations of low dose diclofenac… | Mar, 2027 |
Interested in knowing about Hospira’s Drug Patents Expiring in the next 10 years?
How many Hospira patents are Alive/Dead?
How Many Patents did Hospira File in Different Countries?
Countries in which Hospira Filed Patents
| Country | Patents |
| United States Of America | 139 |
| Europe | 138 |
| Australia | 102 |
| Japan | 99 |
| Canada | 66 |
| Germany | 57 |
| Austria | 55 |
| Spain | 33 |
| Hong Kong (S.A.R.) | 24 |
| India | 20 |
| Korea (South) | 18 |
| China | 18 |
| Mexico | 16 |
| Denmark | 11 |
| Israel | 11 |
| Brazil | 10 |
| New Zealand | 9 |
| Singapore | 9 |
| Portugal | 8 |
| Slovenia | 6 |
| Estonia | 6 |
| Slovakia | 6 |
| Malaysia | 6 |
| Norway | 6 |
| Hungary | 5 |
| South Africa | 5 |
| Taiwan | 4 |
| Poland | 4 |
| Saudi Arabia | 4 |
| Indonesia | 4 |
| Cyprus | 4 |
| Croatia | 3 |
| Turkey | 3 |
| Viet Nam | 3 |
| Serbia | 2 |
| Lithuania | 2 |
| Argentina | 2 |
| Peru | 2 |
| Chile | 2 |
| Philippines | 2 |
| Albania | 2 |
| United Kingdom | 2 |
| Malta | 2 |
| Colombia | 1 |
| Uruguay | 1 |
| Ecuador | 1 |
| Tunisia | 1 |
| Morocco | 1 |
| Brunei | 1 |
| United Arab Emirates | 1 |
| Italy | 1 |
Where are Research Centres of Hospira Patents Located?
10 Best Hospira Patents
US6388393B1 is the most popular patent in the Hospira portfolio. It has received 154 citations so far from companies like Intravena, Icu Medical and Becton Dickinson and Company Limited.
Below is the list of 10 most cited patents of Hospira:
| Publication Number | Citation Count |
| US7758560B2 | 154 |
| US20100280486A1 | 153 |
| US20100114027A1 | 120 |
| US6561224B1 | 117 |
| US6524295B2 | 91 |
| US6695829B2 | 89 |
| US20040162263A1 | 84 |
| US8221382B2 | 81 |
| US7273889B2 | 76 |
| US8091727B2 | 75 |
How many inventions of other companies were rejected due to Hospira patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Hospira invention. They couldn’t because Hospira had protected those before them.
Examiners at the USPTO referred 51 Hospira patents in 247 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Hospira patent portfolio are Jpmorgan Chase Bank, Fresenius Kabi Deutschland and Zhejiang Medicine.
List of the Companies whose Patents were rejected citing Hospira –
| Company | Number of Patent Applications that faced Rejection Citing Hospira Patents | Number of Rejections (102 & 103) |
| Jpmorgan Chase Bank | 5 | 10 |
| Fresenius Kabi Deutschland | 5 | 9 |
| Zhejiang Medicine | 3 | 8 |
| Gruenenthal | 3 | 4 |
| Deka Products | 3 | 5 |
| Carmel Pharma | 2 | 3 |
| Hq Specialty Pharma | 2 | 3 |
| Sanofi-Aventis Deutschland | 2 | 9 |
| Crisi Medical Systems | 2 | 11 |
| IBM | 2 | 7 |
Count of 102 and 103 Type Rejections based on Hospira Patents
Top Hospira Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US6942473B2 | 7 |
| US8709310B2 | 6 |
| US7530974B2 | 5 |
| US20040138298A1 | 5 |
| US6613036B1 | 5 |
| US7488311B2 | 4 |
| US7563253B2 | 4 |
| US20040073192A1 | 4 |
| US7273889B2 | 4 |
| US6716867B1 | 4 |
| US7717897B2 | 3 |
| US7527619B2 | 3 |
| US8091727B2 | 3 |
| US6561224B1 | 3 |
| US20100280486A1 | 3 |
What are Hospira key innovation segments?
What Technologies are Covered by Hospira?
The chart below distributes patents filed by Hospira